Senior Programme Manager
The Belgian Health Care Knowledge Centre (KCE) and ZonMw invest a maximum of 9 million euros in the third round of their joint program ‘BeNeFIT’.
Read about BeNeFIT on the ZonMw information page (in Dutch)
DoelmatigheidsOnderzoek & Goed Gebruik Geneesmiddelen
27 oktober 2022
7 februari 2023,
Wilt u indienen? De volledige subsidieoproep kunt u via onderstaande link bekijken. Hierin staat alle specifieke informatie over deze oproep.
The aim of the call is to provide funding for clinical trials that compare the effectiveness of existing health care interventions that are already in use in a given indication, e.g. comparisons between two medications, medical therapy versus surgery, trials investigating optimal timing of surgery etc. The research should be pragmatic and practice-oriented. Trials funded within the BeNeFIT program must be of a non-commercial nature. The different treatment options that are compared in a BeNeFIT trial should concern treatments that are (or have the potential of being) reimbursed by health care payers in Belgium and the Netherlands. Moreover, each BeNeFIT trial should have the potential of generating results with an immediate and important impact on the efficiency of the health care systems in Belgium and The Netherlands.
For both the budget and duration of the proposed trial, no maximum amount is defined.
The BeNeFIT call focuses on comparative effectiveness trials which show clear value for money and have the potential for return on investment. Accepted trial interventions are not limited to drugs or medical devices but also include a broad range of interventions, such as psychotherapy, diet or surgery. Proposals will be selected based on the need for evidence in clinical practice and possible efficiency improvement and potential return on investment for the health care systems. The primary aim of the trial must be of a non-commercial nature.
Research teams from institutions in Belgium and the Netherlands can apply to this call. The sponsor (the main applicant) should be located in one of the two countries and should be supported by a national coordinating centre in the other country. Both Belgian and Dutch centres should participate, ideally with a good regional spread. In Belgium, both French-speaking and Flemish centres should participate.
Medicinal products or medical devices should be marketed in Belgium and the Netherlands. Devices should have a CE label.
You may submit your application via My ZonMw until 7 February 2023, 14:00 CEST
Please contact us with any questions that are not covered in the FAQs. For general queries, please contact Helene Philippo. If you have any technical questions about ZonMw’s online application system please contact the service desk.